SEC Form 4/A · accession 0001216280-26-000002
INTEGRATED BIOPHARMA INC · INBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Eric J Friedman
Director
Period of report
Jun 24, 2026
Accepted (ET)
Jun 25, 2026 · 12:14 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001016504
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.19 | Jun 24, 2026 | A | 50,000 | A | — | Jun 24, 2036 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027.
Remarks
This Amendment corrects Box 9 - Number of Derivative Securities Beneficially Owned Following Reported Transaction from 50 to 50,000.